Renal transplantation - immunosuppressive regimens for children and adolescents (TA99)
Fast, easy summary view of NICE guidance on 'chronic kidney disease'
NICE has made the following recommendations about the use of immunosuppressive drugs in children and adolescents receiving kidney transplants:
Basiliximab and daclizumab
Doctors should consider using basiliximab or daclizumab for induction therapy. These drugs should only be used with a combination of other drugs that includes ciclosporin.
Tacrolimus is a calcineurin inhibitor and can be used instead of ciclosporin when a person needs a calcineurin inhibitor as part of their initial therapy or maintenance therapy.
Doctors should consider using mycophenolate mofetil as part of immunosuppressive treatment after kidney transplantation only when a person has to stop taking a calcineurin inhibitor, or has to take a lower dose.
NICE does not recommend the use of mycophenolate sodium as part of immunosuppressive regimens for children or adolescents undergoing kidney transplantation.
NICE does not recommend the use of sirolimus as part of immunosuppressive regimens for children or adolescents undergoing kidney transplantation, except when a patient has had to stop taking calcineurin inhibitors because of their side effects.
- TA99 Renal transplantation - immunosuppressive regimens for children and adolescents: guidance (web format)
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: chronic kidney disease
This page was last updated: 11 February 2011
- Web format
- Quick reference guide (PDF)
- Full Guidance (PDF)
- TA99 Cyffuriau i atal trawsblaniadau aren mewn plant a phobl ifanc rhag cael eu gwrthod: deall canllawiau NICE
Information for the public
Implementation tools and resources
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.